| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/17/2008 | WO2008006189A1 Mimotope receptors and inhibitors for platelet- platelet and platelet-endothelium interactions |
| 01/17/2008 | WO2008006125A1 Antimicrobial peptides |
| 01/17/2008 | WO2007138199A3 Recombinant or transgenic factor vii composition, each factor vii molecule having two n-glycosylation sites with defined glycan units |
| 01/17/2008 | WO2007137303A3 Permeability of blood-brain barrier |
| 01/17/2008 | WO2007136817A3 Substituted aryl piperidinylalkynyladenosines as a2ar agonists |
| 01/17/2008 | WO2007136641A3 Methods of treating acute blood loss anemia with a cross-linked hemoglobin blood substitute |
| 01/17/2008 | WO2007134127A3 Agents for imaging apoptosis |
| 01/17/2008 | WO2007130501A3 Combination therapy for treatment of cancer |
| 01/17/2008 | WO2007113689A3 Use of ww protein domain for inhibiting activation of map kinases |
| 01/17/2008 | WO2007106120A3 Serum albumin binding peptides for tumor targeting |
| 01/17/2008 | WO2007103548A3 Novel antibiotic compositions |
| 01/17/2008 | WO2007100898A3 Treatments for neurological disorders |
| 01/17/2008 | WO2007098557A8 Regulation of immune responses by modulation of the function of antigen presenting cells |
| 01/17/2008 | WO2007086093A3 Inhibitors of cell migration mediated by h-prune-gsk-3 complex and uses in antitumoral therapy |
| 01/17/2008 | WO2007084954B1 Selective inhibition of ig20 splice variants to treat cancers |
| 01/17/2008 | WO2007064759A3 Inhibiting tumour cell invasion, metastasis and angiogenesis through targetting legumain |
| 01/17/2008 | WO2007044668A3 Compstatin and analogs thereof for eye disorders |
| 01/17/2008 | WO2007035474A3 Transdermal delivery peptides and method of use thereof |
| 01/17/2008 | WO2007014051A3 Use of amylin and amylin agonists as cardioprotective or myoprotective agents |
| 01/17/2008 | WO2006105490A3 Compositions and methods for treating diseases associated with phlpp |
| 01/17/2008 | WO2006020498A3 Therapeutic agents and methods for cardiovascular disease |
| 01/17/2008 | WO2005118786A3 Splice variants of peptide yy, neuropeptide y, pancreatic peptide y and amylin, and uses thereof |
| 01/17/2008 | WO2005046571A3 Lactoferrin as an adjuvant in cancer vaccines |
| 01/17/2008 | WO2005037999A3 Treatment of cancer using antibodies to lrrc15 |
| 01/17/2008 | WO2004100899A3 Use of secretin in treatments of disorders associated with the amygdala |
| 01/17/2008 | WO2004072257A3 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | US20080015347 Kind Of Fusion Protein, Gene Encoding It, Expression Method And Use Thereof |
| 01/17/2008 | US20080015337 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 01/17/2008 | US20080015332 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 01/17/2008 | US20080015249 Cancer treatment compositions and method using natural plant essential oils |
| 01/17/2008 | US20080015206 Anti-cancer cyclopenta[G]quinazoline compounds |
| 01/17/2008 | US20080015158 By using a double-stranded RNA (dsRNA); neurodegenerative disorder |
| 01/17/2008 | US20080015154 Methods and systems for neural maintenance and regeneration |
| 01/17/2008 | US20080015153 Pharmaceutical compositions containing the long pentraxin PTX3 |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | US20080015151 Viricide polypeptide having >70% sequence identity to native cyanovirin-N and having strategic cysteine and arginine replacements is covalent modified by water-soluble Polyoxyethylene Glycol to extend half-life, reduce toxicity, immunogenicity, improve pharmacokinetics, bioavailability; envelope viruses |
| 01/17/2008 | US20080015150 Peptides and Derivatives Thereof Showing Cell Attachment, Spreading and Detachment Activity |
| 01/17/2008 | US20080015149 Galectin 11 |
| 01/17/2008 | US20080015148 Suitable for lyophilization, protein capable of binding and inhibiting the biological action of IL-1,histidine, glycine, arginine, sucrose, stability; resistant to degradation, aggregation, oxidation, and other degenerative processes while in the freeze dried state |
| 01/17/2008 | US20080015147 Method for inhibiting neuronal cell death |
| 01/17/2008 | US20080015146 e.g. 3-Amino-1-[(S)-2-(3-tert-butyl-[1,2,4]oxadiazol-5-yl)-pyrrolidin-1-yl]-4-(2,4,5-trifluorophenyl)-butan-1-one; dipeptidyl-peptidase inhibitor; antidiabetic, hypoglycemic agent; metabolic disorders, obesity, non-insulin dependent diabetes |
| 01/17/2008 | US20080015145 Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions |
| 01/17/2008 | US20080015144 Glp- (9-36) Methods and Compositions |
| 01/17/2008 | US20080015143 In Vitro Methods for Detecting Renal Cancer |
| 01/17/2008 | US20080015142 Glycopegylated Follicle Stimulating Hormone |
| 01/17/2008 | US20080015141 Use of a Novel Polymorphism in the Hsgk1 Gene in the Diagnosis of Hypertonia an Use of the Sgk Gene Family in the Diagnosis and Therapy of the Long Qt Syndrome |
| 01/17/2008 | US20080015140 Disinfecting composition |
| 01/17/2008 | US20080015139 Soluble virus-specific T-cell receptor compositions |
| 01/17/2008 | US20080015138 Metal binding compounds, metal binding compositions, and their uses |
| 01/17/2008 | US20080015137 Methods and Compositions for Targeting Macromolecules Into the Nucleus |
| 01/17/2008 | US20080014636 inducer of cytotoxic T cells; use of a tumor antigen protein PBF and a gene encoding the same cancer immunology; tumor marker |
| 01/17/2008 | US20080014624 Isolated cDNA or RNA molecule that encodes a protein of given amino acid sequence; cDNA or RNA comprising a nucleotide sequence; can use for vaccines and chemotherapeutic drugs |
| 01/17/2008 | US20080014623 Nutrient absorption enhancing compositions and methods |
| 01/17/2008 | US20080014609 Methods for Obtaining Thermostable Enzymes, Dna Polymerase I Variants from Thermus Aquaticus Having New Catalytic Activities, Methods for Obtaining the Same, and Applications to the Same |
| 01/17/2008 | US20080014277 Reduced-odor thiol compositions |
| 01/17/2008 | US20080014276 Methods and devices for forming treatment agent carriers |
| 01/17/2008 | US20080014270 Methods for improved lipid metabolism and basal metabolic rate with lactoferrin |
| 01/17/2008 | US20080014265 Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| 01/17/2008 | US20080014254 Stable Crystal Modifications of Dotap Chloride |
| 01/17/2008 | US20080014252 Topical compositions with long lasting effect |
| 01/17/2008 | US20080014250 Bifunctionalized polysaccharides |
| 01/17/2008 | US20080014246 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/17/2008 | US20080014237 Sustained release compositions, process for producing the same and use thereof |
| 01/17/2008 | US20080014231 Treatment articles capable of delivering intensive care and overall treatment simultaneously |
| 01/17/2008 | US20080014218 Use of tight junction agonists to facilitate pulmonary delivery of therapeutic agents |
| 01/17/2008 | US20080014210 Peptides and antibodies to muc 1 proteins |
| 01/17/2008 | US20080014206 drug screening for agents potentially useful in the treatment of Mycobacterium tuberculosis infection; drug resistant antibiotics |
| 01/17/2008 | US20080014201 CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases |
| 01/17/2008 | US20080014200 Combined treatment with 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents |
| 01/17/2008 | US20080014196 Compositions and methods for modulating vascular development |
| 01/17/2008 | US20080014193 Modulation of excitable tissue function by peripherally administered erythropoietin |
| 01/17/2008 | US20080014190 Proteinases destroy cancer tumor's solid structure and kill cancer cells locally |
| 01/17/2008 | US20080014189 Diaminotriazoles useful as inhibitors of protein kinases |
| 01/17/2008 | US20080014188 Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof |
| 01/17/2008 | US20080014187 Compositions and Methods for Treating Hypertension and Inflammation |
| 01/17/2008 | US20080014186 Hla-A24 or Hla-A2 Binding Peptides of Parathyroid Hormone-Related Protein |
| 01/17/2008 | US20080014184 Treating fibromyalgia in a subject who has small intestinal bacterial overgrowth (SIBO) by administering a composition comprising a therapeutic agent selected from an antimicrobial agent, an antibiotic, and combinations thereof |
| 01/17/2008 | US20080014174 Method for treating tumors, infectious diseases, and autoimmune diseases with an activated HLA matching donor-originating lymphocyte |
| 01/17/2008 | US20080014173 N-(4,6-dimethyl-2-pyridinyl)-L-valyl- N-(1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((6-methoxy-1-isoquinolinyl)carboxy)-L-prolinamide; viricide; synergistic with other active ingredients |
| 01/17/2008 | US20080014172 Use of Il-17 in the Treatment of Fertility-Related Disorders |
| 01/17/2008 | US20080014169 Compositions for Topical Enzymatic Debridement |
| 01/17/2008 | US20080014159 Therapy for melanin related afflictions |
| 01/17/2008 | US20080014152 Intranasal delivery of clenbuterol across the cribriform plate and into the brain |
| 01/17/2008 | US20080014144 Methods of Treatment with Drug Loaded Polymeric Materials |
| 01/17/2008 | US20080014143 Methods and compositions for targeting gC1qR/p32 |
| 01/17/2008 | US20080014141 Substance Binding Human Igg Fc Receptor Iib (Fcyriib) |
| 01/17/2008 | DE19907485B4 Virus-Vakzine Virus vaccine |
| 01/17/2008 | DE102006033168A1 Verwendung von Gelatine und einem Vernetzungsmittel zur Herstellung einer vernetzenden therapeutischen Zusammensetzung Use of gelatin and a crosslinking agent for preparing a cross-linking therapeutic composition |
| 01/17/2008 | DE102006031962A1 Amidiertes Insulin Glargin Amidated insulin glargine |
| 01/17/2008 | DE102006031955A1 Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende Process for the preparation of insulin analogues with dibasic B chain end |
| 01/17/2008 | CA2660855A1 Improved antibacterial antisense oligonucleotide and method |
| 01/17/2008 | CA2659814A1 Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof |
| 01/17/2008 | CA2659392A1 Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration |
| 01/17/2008 | CA2658431A1 Attenuation of reperfusion injury |
| 01/17/2008 | CA2657665A1 Method and compositions for treating stroke with fever |
| 01/17/2008 | CA2657618A1 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 01/17/2008 | CA2657581A1 Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors |
| 01/17/2008 | CA2657578A1 Methods of treating obesity using satiety factors |
| 01/17/2008 | CA2657543A1 Antimicrobial peptides |